- Thomson Reuters StreetEvents via Yahoo FinanceSep 20 9:43 AM
This trial has completed patient enrollment with 566 patients randomized to receive either Revascor or placebo across 55 centers in North America. The trial's primary endpoint seeks to ...
... Sclerosing Cholangitis Market 2026 By Conatus Pharmaceuticals, Inc. (US), Sirnaomics, Inc. (US), and HighTide Therapeutics...Market Watch3 days ago
Glucose Dependent Insulinotropic Receptor Market Research Report 2019-2026: By Product, Application, Manufacturer, Sales and SegmentationMarket Watch3 days ago
Peptide Drugs Market Size | Global Share 2019 to 2025, Business Stats, Growth perspective and Forecast 2025Market Watch2 days ago
- related to TAKEDA PHARMACEUTICALS AMERICA, INC